-
Open-Source LLMs Performance on Information Retrieval Tasks for Health Outcomes Research
Mar 10, 2025, 14:00 PM -
Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database
Mar 10, 2025, 14:00 PM -
Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review
Mar 10, 2025, 14:00 PM -
Elephant in the Room: Gap Between the Awareness and Need for Psycho-Social Support for Czech Lymphoma Patients as Captured Through the Analyzes of Social and Traditional Media
Mar 10, 2025, 14:00 PM -
Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
What is the Role of Humans in a World of Artificial Intelligence: An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening
Mar 10, 2025, 14:00 PM -
Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)
Mar 10, 2025, 14:00 PM -
Disease Burden Estimates in Economic Evaluation Studies of Respiratory Syncytial Virus (RSV) Maternal Immunization: A Systematic Review
Mar 10, 2025, 14:00 PM -
Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis
Mar 10, 2025, 14:00 PM -
An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States
Mar 10, 2025, 14:00 PM -
Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)
Mar 10, 2025, 14:00 PM -
Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System
Mar 10, 2025, 14:00 PM -
How HTA Should Consider the Global Value of Health Products to Support Public Decision?
Mar 10, 2025, 14:00 PM -
Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US
Mar 10, 2025, 14:00 PM -
Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program
Mar 10, 2025, 14:00 PM
